Gene expression identifies heterogeneity of metastatic behavior among gastrointestinal stromal tumors

BACKGROUND: Adjuvant imatinib is useful in patients with gastrointestinal stromal tumors (GIST) at high risk of recurrence. At present, the risk of recurrence is determined based on tumor size, mitotic rate, tumor site, and tumor rupture. Previous studies using various biochemical pathways identifie...

Descripción completa

Detalles Bibliográficos
Autores principales: Skubitz, Keith M., Geschwind, Kate, Xu, Wayne W., Koopmeiners, Joseph S., Skubitz, Amy P. N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4752787/
https://www.ncbi.nlm.nih.gov/pubmed/26873324
http://dx.doi.org/10.1186/s12967-016-0802-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4752787/
https://www.ncbi.nlm.nih.gov/pubmed/26873324
http://dx.doi.org/10.1186/s12967-016-0802-3

Ejemplares similares